Clinical Trial Update: Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completed evaluating strategies to prevent negative reactions (fainting) in first-time blood donors to encourage subsequent donations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Syncope
• Vasovagal Syncope

Snippet

Sponsor: Ohio University | Conditions: Syncope, Vasovagal | Phase 2 | Status: COMPLETED